chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt like throat was swollen; Difficulty chewing any food; Moved slower then normal.; Difficulty swallowing; Could not perform sexual intercourse.; Felt really drained of energy all day long.; Felt really tired all day and night, at times I couldn't keep my eyes open.; Diarrhea; Fever; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 30Aug2021 at 15:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included mental health issues. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included aripiprazole (MANUFACTURER UNKNOWN) taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 04Aug2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 31Aug2021 at 15:00, the patient felt really tired all day and night, at times the patient could not keep the eyes open, felt really drained of energy all day long. The patient also had diarrhea, fever, moved slower than normal, difficulty chewing any food, difficulty swallowing, felt like throat was swollen and was unable to perform sexual intercourse. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events felt really tired all day and night, at times could not keep the eyes open, felt really drained of energy all day long, diarrhea, fever, moved slower than normal, difficulty chewing any food, difficulty swallowing, felt like throat was swollen and could not perform perform sexual intercourse were resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
The patient developed a pronounced tic several weeks after inoculation.  She has no history of a tic disorder.
brain fog; body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Mar2021 14:00 (Batch/Lot number: unknown) at the age of 33 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: WELLBUTRIN; KYLEENA. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 Immunisation, reaction(s): "Has anxiety". The following information was reported: FEELING ABNORMAL (non-serious) with onset 10Mar2021, outcome "not recovered", described as "brain fog"; PAIN (non-serious) with onset 10Mar2021, outcome "not recovered", described as "body aches". Therapeutic measures were not taken as a result of feeling abnormal, pain.  Additional information: The patient received vaccine at hospital. Patient did not received other vaccine in four weeks. Patient began having brain fog and body aches several days after second vaccination. Symptoms have continued with no cessation. Patient did not had covid prior vaccination. Patient was not tested for covid post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On March 10 (the day after my vaccine) I felt the normal body aches and had a pretty bad headache. That all went away in the evening on March 10. Since that day I have had off and on dizziness/lightheadedness. On March 19 I fainted in my kitchen. I hit my kitchen table and had a huge knot on my head and bruises all down my left side of my body. My left shoulder still hurts from the fall and I still have a small knot on my head (left side just above my left eye on my forehead). I went to my primary care doctor on  March 24 and reported the event. I asked if it could be related to the COVID vaccine and she said she wasn't sure since the Jansen one was so new, but that she had seen these effects from the other two vaccines.  At the doctor's office my blood pressure was on the lower end (110/60). My normal blood pressure runs about 118/70. They ran some blood work and that all came back normal. They did an EKG in the office, but my blood pressure stayed pretty close to the same as it was the first reading. They then sent me to get a CT scan on my head, which also came back normal. She did diagnose me with a concussion. I was out of work the entire week (March 22-March 26) due to this. She also ordered me to have an echo done. While at the office for the echo, my blood pressure ran 99/46 (this was on March 31). The results of the echo came back normal.  I also got a monitor to wear for 72 hours on March 31. I took that to the doctor on April 5 and I am still waiting on results from that.  Since the event on March 19, I have had headaches and body aches. I have also had slight lightheadedness off and on.
Swelling on left side of neck / Bump in neck went away; Bump on his injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling on left side of neck / Bump in neck went away) and VACCINATION SITE MASS (Bump on his injection site arm) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced SWELLING (Swelling on left side of neck / Bump in neck went away) and VACCINATION SITE MASS (Bump on his injection site arm). At the time of the report, SWELLING (Swelling on left side of neck / Bump in neck went away) and VACCINATION SITE MASS (Bump on his injection site arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Significant follow up appended. Outcome of event Neck swelling updated to Resolved
Fever (102.8), severe headache, moderate body aches, mild nausea.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 25-FEB-2014, the patient was vaccinated with ZOSTAVAX lot # H020844 (expiry date 20-FEB-2014). On 25-FEB-2014, 1 day after onset of therapy the patient was administered an expired dose of ZOSTAVAX. No adverse effects reported. The outcome of was administered an expired dose of ZOSTAVAX and no adverse effects was unknown. Additional information has been requested.
Patient fully vaccinated (J&J), but not boosted, admitted to the hospital on 6/30/22 with COVID-19 and associated hypoxia. Patient expired on 7/1/22. Patient was admitted after dose #1 of J&J vaccine.
Redness and swelling at injection site within 5 hours. Travels to elbow. Saw a Dr on 11-13-06, placed on antibiotic. Arm still red and swollen. Recommended ice to be used.
pt recv vax11MAR96 & 15APR96 pt exp spasms in rt upper quad;lab eval on 15APR96 revealed elevated liver function tests & LDH;tx w/two courses of Zithromax for poss pleurisy or pneumonia;gall stones, pleurisy & pneumonia were r/o;
Felt like a funny flu; Both arms felt sore; Whole upper body felt weak; Loss of appetite; Funny feeling in her stomach; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Felt like a funny flu), PAIN IN EXTREMITY (Both arms felt sore), MUSCULAR WEAKNESS (Whole upper body felt weak), DECREASED APPETITE (Loss of appetite) and ABDOMINAL DISCOMFORT (Funny feeling in her stomach) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergy to Sulfa) and Penicillin allergy.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced INFLUENZA (Felt like a funny flu), PAIN IN EXTREMITY (Both arms felt sore), MUSCULAR WEAKNESS (Whole upper body felt weak), DECREASED APPETITE (Loss of appetite), ABDOMINAL DISCOMFORT (Funny feeling in her stomach) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA (Felt like a funny flu), PAIN IN EXTREMITY (Both arms felt sore), MUSCULAR WEAKNESS (Whole upper body felt weak), DECREASED APPETITE (Loss of appetite), ABDOMINAL DISCOMFORT (Funny feeling in her stomach) and HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up included no new information.
inadvertently administered Bexsero instead of Menveo; This case was reported by a consumer via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA94A, expiry date 2nd February 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th August 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 12th August 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The office manager reported that a 12 year patient was inadvertently administered the Bexsero vaccine instead of the Menveo vaccine required by the school, which led to wrong vaccine administered. The reporter consented to follow up.
1 days p/vax pt devel severe h/a & muscle aches & felt feverish w/o a fever;sc cont through MD visit on 17SEP;pt felt somewhat better on 18SEP;
Information has been received from a physician concerning a 10 week old male who, post vax, became very fussy and inconsolable. On 11/25/98, the pt was seen by a physician who noted the pt to be less irritable. On an unspecified date, the pt recovered. Additional information has been requested. Follow up provided no additional data.
Typhoid fever vaccine on 8/21/02 9:55 unusual headache, blurred vision and diarrhea, bed ridden for at least 51x (6) hrs.
Red Rash from injection site covering bicep; Dose Number: 3; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 78-year-old male patient received bnt162b2 (BNT162B2), administration date 12Nov2021 (Batch/Lot number: unknown) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Dose brand=Pfizer, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Dose brand=Pfizer, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 12Nov2021, outcome "unknown", described as "Dose Number: 3"; VACCINATION SITE RASH (non-serious) with onset 13Nov2021, outcome "unknown", described as "Red Rash from injection site covering bicep". Therapeutic measures were not taken as a result of vaccination site rash. Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Device date was 15Nov2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Numb left palm 5 minutes after shot, stabbing pain in left ear 15 minutes after shot, numb left face and tongue 20 minutes after shot. I went to the ER. they said it could not be a reaction to the shot. They ran tests. They admitted me to hospital to get MRI. After all tests complete a neurologist talked to me via an tablet . She said it was a reaction from the shot. Since October 30th shot I have had periodic left face and tongue numbness.
patient experienced COVID and considering to take Paxlovid; patient experienced COVID and considering to take Paxlovid; Dose 5 administered with Moderna; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) at the age of 70 years for covid-19 immunisation; BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 70 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Celiac disease" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "patient experienced COVID and considering to take Paxlovid"; INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown", described as "Dose 5 administered with Moderna". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive.  Clinical information: It was reported that, she explained that she had taken four doses of the Pfizer COVID-19 Vaccine and the original primary series and two booster doses and that every dose made her very sick and each one made more sick then the one before. She suspects that this reaction was caused by gluten or an egg-derived ingredient. In order to take Paxlovid, she wanted to make sure that this medication does not contain any gluten. She described to be already very sick from COVID. She also said that she took a third booster dose (last dose) from Moderna, and that vaccine did not make her sick at all. So, the patient was trying to find a Moderna Bivalent booster to take, and she did find where they are. The patient just didn't have time to get the booster before she came down with COVID.  The information on the batch/lot number for BNT162b2, BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the drug ineffective (LOE) and COVID-19 cannot be ruled out.
On Jan 12, the patient developed  positional vertigo and nausea as well as sore arm. Vertigo resolved when she fell asleep.  Vertigo returned on Jan 16 and17.  Diarrhea occurred 6 times on Jan 17.  The patient noticed significant diffuse loss of hair from January 16 to 19. She continues to have some nausea.
Both legs got rash.  Collection of erythematous papules and vesicles over lateral and anterior thighs.  Appear to be 1-2 mm.
Her arm started to swell that night and she developed hives.  By the next morning the swelling was about half the size of a grapefruit and very red.  It was also itchy. Patient took Advil for two days.  Her arm is almost back to normal.  She states the redness is fading and her arm is almost flat. The hives have disappeared. Her arm is still a little itchy.  Provider encouraged pt to take Benadryl.
sharp pain from shoulder blade down to fingers. pain started immediately after the shot. relief provided by steroid shot 10/9/19
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 0688H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 31-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) to be not related.    Concomitant product information was not provided.  No adverse reaction was reported by the patient.  Treatment information was not provided.   This case was linked to MOD-2022-486834 (Patient Link).
swelling, redness, warmth and tenderness of upper arm extending from injection site around outer upper arm
light headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (light headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 001C21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LEVOTHYROXINE, FLUOXETINE and ATORVASTATIN for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced HEADACHE (light headache). At the time of the report, HEADACHE (light headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medicine: Supplements Treatment Tylenol tablets different strength, Tylenol liquid and heating of muscles by warmer.   This case was linked to US-MODERNATX, INC.-MOD-2021-089631 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089631:
Blurred vision and limited peripherical vision area. Dizziness. Note: Received 4 shots of Anthrax on the following dates: 8 Mar 2003, 12 Apr 2003, 18 May 2003, 22 Oct 2003.
Information has been received from a physician concerning an 85 year old female with heart and lung problems, arthritis, penicillin allergy, sulfa allergy and codeine allergy who on 07-OCT-2008 was vaccinated intramuscularly with the first 0.5 mL dose of PNEUMOVAX (LOT# 660717/0224X). On 10-OCT-2008 the patient experienced swelling, pain and redness at the site of injection. The patient was treated with cold compresses. Subsequently, the patient recovered from the events. The patient sought medical attention in the office. This is one of several reports received from the same source. Additional information has been requested.
Severe headache; Nausea; High fever; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of HEADACHE (Severe headache), NAUSEA (Nausea) and PYREXIA (High fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced HEADACHE (Severe headache), NAUSEA (Nausea) and PYREXIA (High fever). At the time of the report, HEADACHE (Severe headache), NAUSEA (Nausea) and PYREXIA (High fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Symptoms started in Feb. 29 08.  Pt came in with emesis and loose stool.  3/17/08 again pt came in with emesis and diarrhea x5 days, no bloody stools.  4 8 08 h/o emesis, not tolerating liquids.  4/10/08 continues with vomiting not tolerating liquids, dehydrated went to ER.  07/02/2008 MR received for DOS 4/10-12/2008 with D/C DX:  Intussusception. Infant presented to ER for 3rd time with c/o 4 day hx of emesis, abdominal tenderness and bloody stools. (+) URI sx-mild productive cough. PE WNL except crying and agitation and periods of staring and difficulty with arousal. Ileocolic Intussusception reduced by BE on 4/11/08.
Medical Asst gave Varicella vaccine instead of influenza vaccine. reported 11/19/21.
Temperature excursions; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). In November 2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.  Reporter stated that the dose of Moderna COVID-19 vaccine after a temperature excursion at the frozen range reaching a temperature <-50°C then the vaccine was then placed in a different freezer which experienced a temperature excursion on 19-Nov-2021, reaching a maximum of 10.8°F for 5 hours and 31 minutes.   Most recent FOLLOW-UP information incorporated above includes: On 23-Nov-2021: Follow up received on 23 Nov 2021 contain Patient demographics were updated.